<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
      version="3.7"
      xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-7.xsd">
   <titleInfo>
      <title>Data on phenylalanine-to-tyrosine ratios in assessment of tetrahydrobiopterin (BH4)-responsiveness in patients with hyperphenylalaninemia</title>
   </titleInfo>
   <name type="personal" usage="primary">
      <namePart type="given">Barbka Repic</namePart>
      <namePart type="family">Lampret</namePart>
      <displayForm>Lampret, Barbka Repic</displayForm>
      <affiliation>Clinical Institute for Special Laboratory Diagnostics, University Children's Hospital, UMC Ljubljana, Ljubljana 1000, Slovenia</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Mojca Zerjav</namePart>
      <namePart type="family">Tansek</namePart>
      <displayForm>Tansek, Mojca Zerjav</displayForm>
      <affiliation>Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, UMC Ljubljana, Faculty of Medicine, University of Ljubljana, Bohoriceva 20, Ljubljana 1000, Slovenia</affiliation>
      <affiliation>Faculty of Medicine, University of Ljubljana, Ljubljana 1000, Slovenia</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Blaz</namePart>
      <namePart type="family">Groselj</namePart>
      <nameIdentifier type="orcid">https://orcid.org/0000-0003-4799-2978</nameIdentifier>
      <displayForm>Groselj, Blaz</displayForm>
      <affiliation>Faculty of Medicine, University of Ljubljana, Ljubljana 1000, Slovenia</affiliation>
      <affiliation>Institute of Oncology Ljubljana, Ljubljana 1000, Slovenia</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Jaka</namePart>
      <namePart type="family">Sikonja</namePart>
      <displayForm>Sikonja, Jaka</displayForm>
      <affiliation>Faculty of Medicine, University of Ljubljana, Ljubljana 1000, Slovenia</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Tadej</namePart>
      <namePart type="family">Battelino</namePart>
      <nameIdentifier type="orcid">https://orcid.org/0000-0002-0273-4732</nameIdentifier>
      <displayForm>Battelino, Tadej</displayForm>
      <affiliation>Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, UMC Ljubljana, Faculty of Medicine, University of Ljubljana, Bohoriceva 20, Ljubljana 1000, Slovenia</affiliation>
      <affiliation>Faculty of Medicine, University of Ljubljana, Ljubljana 1000, Slovenia</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <name type="personal">
      <namePart type="given">Urh</namePart>
      <namePart type="family">Groselj</namePart>
      <nameIdentifier type="orcid">https://orcid.org/0000-0002-5246-9869</nameIdentifier>
      <displayForm>Groselj, Urh</displayForm>
      <affiliation>Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, UMC Ljubljana, Faculty of Medicine, University of Ljubljana, Bohoriceva 20, Ljubljana 1000, Slovenia</affiliation>
      <affiliation>Faculty of Medicine, University of Ljubljana, Ljubljana 1000, Slovenia</affiliation>
      <role>
         <roleTerm type="text">author</roleTerm>
      </role>
   </name>
   <typeOfResource>text</typeOfResource>
   <genre>article</genre>
   <originInfo>
      <dateIssued encoding="w3cdtf" keyDate="yes">2022-02-02</dateIssued>
   </originInfo>
   <language>
      <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
      <languageTerm type="text">English</languageTerm>
   </language>
   <abstract>Blood phenylalanine-to-tyrosine (Phe/Tyr) ratio is an important indicator of metabolic control in phenylketonuria patients. We present the data that highlights the role of Phe/Tyr-ratio in the evaluation of tetrahydrobiopterin (BH₄)-responsiveness in patients with hyperphenylalaninemia. Our data complements the results from the original research article by Tansek et al., 2012 [1]. We performed a BH₄-loading test in 32 patients after four days of increased protein intake (2000 mg/kg body weight). Blood sampling was performed 96, 72, 48, 24, 16 h, and moments before oral administration of BH₄ in a dose of 20 mg/kg body weight. Additional blood samples were collected 8 and 24 h after its administration. Phenylalanine (Phe) and Tyrosine (Tyr) levels were determined from dried blood spots by tandem mass spectrometry. Phe/Tyr-ratio reached a plateau after three days of increased dietary protein intake. Fifteen patients (47%) responded to BH₄, defined as a decrease of Phe-of at least 30% after 24 h of BH₄ administration. Phe/Tyr-ratios were significantly higher in non-responders compared to responders. In the responder group, Phe/Tyr-ratios decreased in average of 67% (p = 0.001) and 45% (p = 0.001) after 8 and 24 h of BH₄ administration, respectively. Phe/Tyr-ratio decreased after 8 h of drug administration also in the non-responder group, but not 24 h after administration. </abstract>
   <note type="admin">Pre-press version</note>
   <subject>
      <topic>Phenylketonuria</topic>
   </subject>
   <subject>
      <topic>Phenylalanine-to-tyrosine ratio</topic>
   </subject>
   <subject>
      <topic>Tetrahydrobiopterin</topic>
   </subject>
   <subject>
      <topic>BH4-responsiveness</topic>
   </subject>
   <subject>
      <topic>Hyperphenylalaninemia</topic>
   </subject>
   <subject>
      <topic>Tandem mass spectrometry</topic>
   </subject>
   <relatedItem type="host">
      <titleInfo>
         <title>Data in Brief</title>
      </titleInfo>
      <originInfo>
         <publisher>Elsevier Inc.</publisher>
      </originInfo>
      <identifier type="issn">2352-3409</identifier>
      <part>
         <text type="year">2022</text>
         <text type="month">02</text>
         <text type="day">02</text>
         <extent unit="pages">
            <start>107926</start>
         </extent>
      </part>
   </relatedItem>
   <identifier type="doi">10.1016/j.dib.2022.107926</identifier>
   <location>
      <url>http://dx.doi.org/10.1016/j.dib.2022.107926</url>
   </location>
   <identifier type="pii">S2352-3409(22)00138-X</identifier>
   <accessCondition type="use and reproduction"
                    displayLabel="Creative Commons Attribution 4.0 Generic (CC BY 4.0)">
      <program xmlns="https://data.crossref.org/schemas/AccessIndicators.xsd">
         <licence_ref applies_to="reuse" start_date="2022-02-02"/>
         <licence_ref>http://creativecommons.org/licenses/by/4.0/</licence_ref>
      </program>
   </accessCondition>
   <extension>
      <vendorName/>
      <archiveFile/>
      <originalFile>file:/C:/Users/Carlos.Martinez/OneDrive%20-%20USDA/XML_projects/OpenAccess/OpenAccess/transform/source/sourcefiles/576450669703096969-00001/2352-3409/aip/S235234092200138X/S235234092200138X.xml</originalFile>
      <workingDirectory>C:\Users\Carlos.Martinez\OneDrive - USDA\XML_projects\OpenAccess\OpenAccess\transform\result\</workingDirectory>
   </extension>
</mods>
